Lund, Sweden, 2015-11-25 16:35 CET (GLOBE NEWSWIRE) --
EXINI Diagnostics AB (publ) held an Extra General Meeting on 25 November 2015 in Lund.
At the general meeting it was noted that the board members Henrik Perlmutter (as well as chairman), Olof Jarlman, Jan Erik Hedborg and Johan Wennerholm had announced that they would resign as board members in connection with the Extra General Meeting.
The general meeting elected Magnus Aurell, Mark Baker, Sheldon Hirt and Klas Themner as new board members, for the period until the next Annual General Meeting, and resolved that there will be no remuneration for the board members. After the general meeting Sheldon Hirt was appointed chairman of the board.
Lund, November 25, 2015
EXINI Diagnostics AB (publ)
Board of Directors
For more information, please contact:
Magnus Aurell, CEO
Phone: +46 46 286 54 25
E-mail: magnus.aurell@exini.com
About EXINI Diagnostics AB (publ)
EXINI Diagnostics AB (publ) offers advanced solutions for medical decision support to hospitals worldwide. The system is based on advanced image analysis by artificial intelligence and can make its own interpretation of medical images and provide diagnostic suggestions. In this way the system is used as a decision support for the diagnosing doctor. EXINI is working with products for the diagnosis of some of the most frequent endemic diseases such as cancer, coronary heart disease, dementia and Parkinson's disease. EXINI is listed on the stock market NASDAQ OMX First North. Consensus acts as Certified Adviser.
________________________________________________________________________
EXINI Diagnostics AB, Ideon Science Park, Scheelevägen 27, SE-223 70 Lund, Sweden
Phone: +46 46 286 54 20, Fax: +46 46 286 54 29, info@exini.com, www.exini.com
